HOME >> BIOLOGY >> NEWS
Intel and Fred Hutchinson to explore the use of nanotechnology tools for early disease detection

STANFORD, Calif., Oct. 23, 2003 - Intel Corporation and the Fred Hutchinson Cancer Research Center today announced a collaborative research effort to apply Intel's expertise in nanotechnology to develop improved methods of studying, diagnosing and preventing cancer. The announcement was made at the BioSilico Seminar, held at Stanford University.

"To launch the effort, Intel is building an Intel Raman Bioanalyzer System at the Fred Hutchinson Cancer Research Center in Seattle," said Andrew Berlin, lead researcher, Intel's Precision Biology program. "The instrument beams lasers onto tiny medical samples, such as blood serum, to create images that reveal the chemical structure of molecules. The goal is to determine if this technology, previously used to detect microscopic imperfections on silicon chips, can also detect subtle traces of disease."

"This collaboration is a unique and exciting interaction," said Dr. Lee Hartwell, Nobel Laureate and center president and director. "Biologists have never before had such a method for studying the molecular structure of biology. This is true discovery-based research; we don't know what we will see or learn. It may lead to a new era of molecular diagnostics and improved methods of early disease detection."

"Intel enthusiastically endorses Dr. Hartwell's vision of Early Disease Detection and I am thrilled to have this opportunity to help accelerate progress towards it realization. This is collaborative research at its best. Together we can learn how best to adapt advances in nanotechnology to solve some of the most pressing problems in medicine and biology," said David Tennenhouse, vice president, Intel's Corporate Technology Group and director of research.

The Intel Raman Bioanalyzer System is based on a technique known as Raman spectroscopy Intel uses this technique to analyze subtle chemical compositions during the chip fabrication process. By shining a laser beam at an object, molecules with
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
23-Oct-2003


Page: 1 2

Related biology news :

1. APS recognizes Intel high school finalists for experiments in physiology
2. Intelligent design: The new big tent for evolutions critics
3. McGill Centre for Intellectual Property Policy receives $3 million SSHRC Grant
4. Intelligent device shows promise in physical activity measurement market
5. Intels Gordon Moore and CIs Claude Gascon to receive major award
6. American Association for Cancer Research honors Fred Hutchinson Cancer Research Center investigator
7. Fred Hutchinson Cancer Research Center, University of Washington join in national effort to study health impact of toxic substances
8. Hutchinson Center researchers first to induce state of suspended animation in model vertebrate organism
9. Digging for genetic fossils: Hutchinson Center researchers solve structure of ancient biological molecule
10. Fred Hutchinson Cancer Research Center to lead international team to accelerate investigation of immune-related genes
11. Hutchinson Center researcher awarded Block lectureship

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2020)... LAUDERDALE, Fla. (PRWEB) , ... March 19, 2020 , ... ... bestowing his talents as host to the informational show "In Depth". The TV program ... people. "In Depth" is shifting gears on a new episode with a dive into ...
(Date:3/11/2020)... ... March 11, 2020 , ... USARAD Holdings Inc., the ... and several healthcare VC firms introduces a first of its kind COVID-19 screening ... and has caused over 4,000 fatalities to date. Over the years, USARAD through ...
(Date:3/5/2020)... ... March 05, 2020 , ... ... partnership agreement with Phoenestra GmbH to accelerate Cytonus’ existing products and to expand ... Diego, California. Phoenestra is a biotech company located in Austria. , Phoenestra ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... ... ... In a free session on Tuesday, March 10, 2020 at 11am ... MS, Vice President Rare, Orphan and Pediatric Diseases, and Rachael Young, Associate Director, Feasibility ... sites and sponsors. , When planning a rare disease clinical trial, drug developers can ...
(Date:2/19/2020)... ... February 18, 2020 , ... Shoreline Biome, a ... strain level, recently unveiled a novel DNA isolation product. , Shoreline Rapid Prep ... high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB from ...
(Date:2/11/2020)... ... February 11, 2020 , ... Synagro Technologies, Inc. ... today announced that the City of Fort Worth has partnered with Synagro of ... in April of 2020, Synagro will assume operation of the city’s current biosolids ...
(Date:2/3/2020)... ... February 03, 2020 , ... ... Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex successor to Holotype ... a best-in-class product featuring locus-multiplexing and short library preparation, for HLA genotyping from ...
Breaking Biology Technology:
Cached News: